A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 4,388 shares of NVO stock, worth $469,121. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,388
Previous 3,090 42.01%
Holding current value
$469,121
Previous $441 Million 18.46%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $154,552 - $188,755
1,298 Added 42.01%
4,388 $522 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $271,240 - $325,840
3,090 New
3,090 $320 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $241B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Foster Dykema Cabot & Partners, LLC Portfolio

Follow Foster Dykema Cabot & Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & Partners, LLC with notifications on news.